Puberty, Precocious: Clinical Trials

74 trials for Puberty, Precocious, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 13 recruiting, 11 unknown, 4 not yet recruiting. 16 Phase 3, 13 Not applicable, 9 Phase 4, 5 Phase 2, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 316Completed 13, Active not recruiting 1, Recruiting 1, Unknown 1
Not applicable13Unknown 5, Completed 3, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 49Completed 5, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 25Completed 4, Not yet recruiting 1
Early Phase 12Completed 1, Withdrawn 1
Phase 12Completed 1, Unknown 1

Follow Puberty, Precocious: new trials by email Literature Review of Puberty, Precocious trials Research Report on Puberty, Precocious

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
(Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty
(Z)-endoxifen - Precocious Puberty, Gonadotropin-dependent
Phase 2Not yet recruitingAtossa Therapeutics, Inc.62027-03-012026-10-09
INSL3 as a Biomarker of Pubertal Activation: Role in Evaluating Precocious and Delayed Puberty
Precocious Puberty, Central, Delayed Puberty
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1002026-10-022026-10-06
A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty
Leuprorelin - Central Precocious Puberty
Phase 4RecruitingLG Chem432026-08-012026-07-29
Clinical Study of Traditional Chinese Medicine in the Treatment of Phlegm-dampness Intrinsic Precocious Puberty
Sanghe Jianghuo Granules, Placebo - Precocious Puberty
Not applicableNot yet recruitingChildren's Hospital of Fudan University2002026-07-012026-06-09
Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty
administered "Mulberry and Lotus Leaf Heat-Clearing Granules," with the following drug composition: mulberry leaves, lotus leaves, fresh rehmannia, anemarrhena, scutellaria, atractylodes, etc., 10% drug-containing placebo, for a period of 3 months. - Puberty, Precocious
Early Phase 1WithdrawnChildren's Hospital of Fudan University2026-05-012026-07-06
Clinical Observation of Qingwei Huazhuo Decoction (Product: Jinsaiyu) in Improving Children With Precocious Puberty of Phlegm-Dampness Internal Accumulation Type
Qingwei Huazhuo Decoction: Mulberry leaf powder, lotus leaf powder, malt powder, hawthorn powder, Poria cocos powder, gardenia powder, dried tangerine peel powder, licorice powder, momordica grosvenor, diet and exercise education - Precocious Puberty
Not applicableTerminatedChildren's Hospital of Fudan University942026-03-302026-05-05
Basal LH Threshold for the Diagnosis of Central Precocious Puberty
Precocious Puberty, Central
RecruitingUniversity Hospital, Strasbourg, France1002026-03-022026-10-07
Hypiend - Multicomponent Behavioral Intervention in Pre-puberal Children (Hypiend-PPC)
Multi-Component Behavioral intervention, Information - Precocious Puberty, Central, Executive Dysfunction
Not applicableActive not recruitingSciensano7002025-09-152026-08-03
Spexin and Phoenixin-20 in Girls With Central Precocious Puberty
Central Precocious Puberty (CPP), Puberty Disorders
CompletedKayseri City Hospital1432024-12-012026-01-22
A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty
intradermal needles, Ziyinxiehuo Granules of traditional Chinese Medicine - Precocious Puberty, Treatment
Phase 3RecruitingChildren's Hospital of Fudan University1702024-09-152026-03-16
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)
Debio 4326 - Central Precocious Puberty
Phase 3Active not recruitingDebiopharm International SA562024-07-312026-10-23
Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP
Triptorelin pamoate(15mg), Triptorelin acetate (3.75mg) - Central Precocious Puberty
Phase 4Not yet recruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University1342024-07-012024-07-05
Observation of Environment and Reproductive-Endocrine Effects
Hypogonadism, Hypergonadism
RecruitingNational Institute of Environmental Health Sciences (NIEHS)3002024-07-012026-09-28
First Observatory of Precocious Puberty.
Puberty, Precocious
Active not recruitingHospices Civils de Lyon33602024-06-262026-10-27
Idiopathic Central Precocious Puberty and Associated Neurodevelopmental Syndromes and Pathologies: Evaluation of Frequency and Comparison of Diagnostic and Developmental Characteristics
Central Precocious Puberty (CPP)
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna3002024-03-132026-03-12
A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China
Central Precocious Puberty
CompletedTakeda14772023-12-132026-01-21
Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty
Metformin Hydrochloride tablet, Placebo, Lifestyle intervention - Puberty, Precocious
Not yet recruitingCopenhagen University Hospital at Herlev15002023-09-012023-07-24
Evaluate the Efficacy and Safety of DWJ108J
Leuprolide Acetate 11.25 MG/ML - Central Precocious Puberty
Phase 3UnknownDaewoong Pharmaceutical Co. LTD.792023-08-012023-09-06
Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty
Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide - Puberty; Precocious, Central
Phase 3CompletedForesee Pharmaceuticals Co., Ltd.942023-06-022026-07-20
Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context
Environmental health measures - Puberty, Precocious, Breast
Not applicableRecruitingLille Catholic University622023-05-152026-03-17

Showing 20 of 74. Sign in to see all of them.

Narrower conditions

Hypogonadism (5)  ·  Puberty, Delayed (4)  ·  Fibrous Dysplasia, Polyostotic (3)  ·  Kallmann Syndrome (3)  ·  Amenorrhea (2)  ·  Endocrine System Diseases (2)  ·  Familial Testotoxicosis (2)  ·  Infertility (2)  ·  Obesity (2)  ·  Overweight (2)  ·  Rare Diseases (2)  ·  Adrenal Hyperplasia, Congenital (1)  ·  Adrenal Insufficiency (1)  ·  Angelman Syndrome (1)

Broader conditions

Gonadal Disorders (73)  ·  Endocrine System Diseases (72)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Musculoskeletal Diseases (6)  ·  Bone Diseases (5)  ·  Congenital Abnormalities (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Bone Diseases, Developmental (4)  ·  Disorders of Sex Development (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genetic Diseases, Inborn (4)  ·  Male Urogenital Diseases (4)  ·  Nutrition Disorders (4)

Interventions

Leuprolide (17)  ·  Triptorelin Pamoate (6)  ·  Gonadotropin-Releasing Hormone (3)  ·  Testolactone (2)  ·  4-hydroxy-N-desmethyltamoxifen (1)  ·  Anastrozole (1)  ·  Diet (1)  ·  Fulvestrant (1)  ·  Hematologic Tests (1)  ·  Injections (1)  ·  Letrozole (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Medicine, Chinese Traditional (1)  ·  Metformin (1)  ·  Sodium Chloride (1)

Sponsors

Children's Hospital of Fudan University (6)  ·  Ipsen (4)  ·  Takeda (4)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (3)  ·  Abbott (2)  ·  AstraZeneca (2)  ·  Daewoong Pharmaceutical Co. LTD. (2)  ·  Debiopharm International SA (2)  ·  National Center for Research Resources (NCRR) (2)  ·  National Institute of Environmental Health Sciences (NIEHS) (2)  ·  Shenzhen Center for Disease Control and Prevention (2)  ·  University of Aarhus (2)  ·  AbbVie (1)  ·  AbbVie (prior sponsor, Abbott) (1)

Countries

United States (21)  ·  China (16)  ·  France (9)  ·  South Korea (6)  ·  Italy (5)  ·  Denmark (4)  ·  Puerto Rico (4)  ·  Argentina (3)  ·  Chile (3)  ·  Israel (3)  ·  Mexico (3)  ·  Turkey (Türkiye) (3)  ·  Belgium (2)  ·  Canada (2)  ·  Russia (2)

Top investigators

Federico Baronio, MD (2)  ·  Natalie D Shaw, M.D. (2)  ·  Alison Boyce, MD (1)  ·  Amnon Zung, MD (1)  ·  Anders Juul, PhD, DMSc (1)  ·  Ariane Baye, PhD (1)  ·  Barry Albertson (1)

Results publications

PMID 23643382, PMID 32870266, PMID 12788881, PMID 14573733, PMID 15132858, PMID 15613419, PMID 16382000, PMID 16606836, PMID 16757106, PMID 16764984, PMID 17074994, PMID 17334928, PMID 17959774, PMID 18272894, PMID 19021638, PMID 19567835, PMID 19951508, PMID 20332248, PMID 20484732, PMID 20696889, PMID 21037178, PMID 21163089, PMID 21209029, PMID 21247312, PMID 21700882, PMID 21860633, PMID 22072740, PMID 22319038, PMID 22344198, PMID 22745237, PMID 22773735, PMID 22904181, PMID 22990093, PMID 22999294, PMID 23378218, PMID 23533228, PMID 24295437, PMID 24476074, PMID 24926950, PMID 25394172, PMID 25803268, PMID 26075496, PMID 28334719, PMID 28472487, PMID 30465166, PMID 31132118, PMID 31319416, PMID 32160304, PMID 32185991, PMID 32480405

NIH funding

2005 (2), 2008 (1), M01RR000064 (1)